v3.21.2
Accrued Liabilities (Tables)
9 Months Ended
Oct. 01, 2021
Accrued Liabilities [Abstract]  
Schedule of Accrued Liabilities
Accrued liabilities in the Condensed Consolidated Balance Sheets consisted of the following:
October 1, 2021December 31, 2020
(In thousands)
Accrued compensation and related benefits$136,759 $98,455 
Accrued taxes53,614 57,286 
Accrued asbestos-related liability47,412 41,626 
Warranty liability - current portion17,594 15,543 
Accrued restructuring liability - current portion7,784 7,889 
Accrued third-party commissions30,352 25,480 
Customer advances and billings in excess of costs incurred30,707 36,737 
Lease liability - current portion35,857 39,695 
Accrued interest8,364 27,153 
Other120,189 104,469 
$488,632 $454,333 
Schedule of Product Warranty Liability
The activity in the Company’s warranty liability consisted of the following:
Nine Months Ended
October 1, 2021October 2, 2020
(In thousands)
Warranty liability, beginning of period$15,543 $15,528 
Accrued warranty expense7,262 5,613 
Changes in estimates related to pre-existing warranties1,401 1,108 
Cost of warranty service work performed(6,716)(7,003)
Acquisition-related liability1,092 — 
Foreign exchange translation effect(277)(255)
Warranty liability, end of period (1)
$18,305 $14,991 
(1) As of October 1, 2021, $17.6 million of the Company’s Warranty liability was included in Accrued expenses, whereas $0.7 million of the Company’s Warranty liability was included in Other liabilities on the Company’s Condensed Consolidated Balance Sheet.
Schedule of Restructuring Reserve by Type of Cost A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Condensed Consolidated Balance Sheets is as follows:
Nine Months Ended October 1, 2021
Balance at Beginning of PeriodProvisionsPaymentsForeign Currency Translation
Balance at End of Period(3)
(In thousands)
Restructuring and other related charges:
Fabrication Technology:
Termination benefits(1)
$5,336 $4,572 $(4,611)$(43)$5,254 
Facility closure costs(2)
591 5,186 (5,555)(18)204 
5,927 9,758 (10,166)(61)5,458 
Non-cash charges(2)
1,033 
10,791 
Medical Technology:
Termination benefits(1)
1,884 2,728 (2,149)(9)2,454 
Facility closure costs and other(2)
297 2,464 (2,735)— 26 
2,181 5,192 (4,884)(9)2,480 
Non-cash charges(2)
— 
5,192 
Total Colfax Corporation:
Total restructuring liability activity$8,108 14,950 $(15,050)$(70)$7,938 
Total Non-cash charges1,033 
$15,983 
(1) Includes severance and other termination benefits, including outplacement services.
(2) Includes the cost of relocating associates, relocating equipment and lease termination expense in connection with the closure of facilities. 
(3) As of October 1, 2021, $7.8 million of the Company’s restructuring liability was included in Accrued liabilities, whereas less than $0.2 million of the Company’s restructuring liability was included in Other liabilities.